Davis Polk advised the sales agent, Cowen, in the offering.Revolution Medicines, Inc. announced it may issue and sell shares of its common stock for up to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
